Literature DB >> 8977327

Genetic control of anti-idiotypic vaccination against coronavirus infection.

M W Yu1, S Lemieux, P J Talbot.   

Abstract

The idiotypic network can be experimentally altered to induce protective immune responses against microbial pathogens. Both internal image and noninternal image anti-idiotypic (anti-Id) antibodies have been shown to trigger antigen (Ag)-specific immune responses. Therefore, mechanisms of anti-Id vaccination appear to go beyond structural mimicry of Ag, but remain undefined. Using the neurotropic murine coronavirus animal model, we have previously shown that a polyclonal noninternal image anti-Id (Ab2) could vaccinate BALB/c mice. To characterize its mode of action, we have examined the immune modulating capability of this Ab2 in vivo in strains of mice with different H-2 haplotypes. Even though only internal image anti-Id are expected to induce non-genetically restricted immunity, this noninternal image Ab2 induced protective immunity in four of eight genetically different strains of mice susceptible to coronavirus infection. These were BALB/c (H-2d), DBA/2 (H-2d), DBA/1 (H-2q), and SWR (H-2q) mice. Protection was generally correlated with the induction of specific antiviral Ab (Ab3) that showed biological properties, such as virus neutralization in vitro, similar to the initial Ab1. To evaluate the genetic implication of the H-2 haplotypes in protection, congenic mice were also tested. Vaccination profiles suggest that cooperation between background gene(s) of the BALB/c mouse with H-2d and H-2q loci is necessary for an optimal protective immune response, although the main genetic element(s) regulating the antiviral response to Ab2 inoculation appeared to be located outside the major histocompatibility complex. These results are consistent with the ability of Ab2 to induce protective antiviral antibodies in genetically different animals by biological mimicry.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8977327      PMCID: PMC7163770          DOI: 10.1002/eji.1830261258

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  23 in total

1.  Identification of an immunodominant linear neutralization domain on the S2 portion of the murine coronavirus spike glycoprotein and evidence that it forms part of complex tridimensional structure.

Authors:  C Daniel; R Anderson; M J Buchmeier; J O Fleming; W J Spaan; H Wege; P J Talbot
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

2.  Monoclonal anti-idiotypic antibody mimicking the principal neutralization site in HIV-1 GP120 induces HIV-1 neutralizing antibodies in rabbits.

Authors:  M S Fung; C R Sun; R S Liou; W Gordon; N T Chang; T W Chang; N C Sun
Journal:  J Immunol       Date:  1990-10-01       Impact factor: 5.422

3.  Administration of noninternal image monoclonal anti-idiotypic antibodies induces idiotype-restricted responses specific for human immunodeficiency virus envelope glycoprotein epitopes.

Authors:  E M Zhou; K L Lohman; R C Kennedy
Journal:  Virology       Date:  1990-01       Impact factor: 3.616

4.  Site-specific alteration of murine hepatitis virus type 4 peplomer glycoprotein E2 results in reduced neurovirulence.

Authors:  R G Dalziel; P W Lampert; P J Talbot; M J Buchmeier
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

5.  Immunogenicity of an engineered internal image antibody.

Authors:  R Billetta; M R Hollingdale; M Zanetti
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

6.  A vaccine against Semliki Forest virus consisting of a monoclonal anti-idiotypic antibody cross-linked to a protein which contains virus-specific T-helper cell epitopes.

Authors:  C A Kraaijeveld; T A Oosterlaken; A Snijders; B J Benaissa-Trouw; G L Ekstijn; H Snippe
Journal:  Antiviral Res       Date:  1992-10-01       Impact factor: 5.970

7.  Anti-idiotype vaccine against Hodgkin's lymphoma: induction of B- and T-cell immunity across species barriers against CD30 antigen by murine monoclonal internal image antibodies.

Authors:  C Pohl; C Renner; M Schwonzen; M Sieber; P Lorenz; M Pfreundschuh; V Diehl
Journal:  Int J Cancer       Date:  1992-04-01       Impact factor: 7.396

8.  Specific modulation of T cells and murine experimental allergic encephalomyelitis by monoclonal anti-idiotypic antibodies.

Authors:  S R Zhou; J N Whitaker
Journal:  J Immunol       Date:  1993-02-15       Impact factor: 5.422

9.  Induction of an anti-hepatitis B surface antigen response in mice by noninternal image (Ab2 alpha) anti-idiotypic antibodies.

Authors:  M R Schick; G R Dreesman; R C Kennedy
Journal:  J Immunol       Date:  1987-05-15       Impact factor: 5.422

10.  Localization of neutralizing epitopes and the receptor-binding site within the amino-terminal 330 amino acids of the murine coronavirus spike protein.

Authors:  H Kubo; Y K Yamada; F Taguchi
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

View more
  1 in total

1.  Characterization of murine coronavirus neutralization epitopes with phage-displayed peptides.

Authors:  M W Yu; J K Scott; A Fournier; P J Talbot
Journal:  Virology       Date:  2000-05-25       Impact factor: 3.616

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.